Literature DB >> 20538836

Plasma volume, albumin, and fluid status in peritoneal dialysis patients.

Biju John1, B Kay Tan, Stephen Dainty, Patrik Spanel, David Smith, Simon J Davies.   

Abstract

BACKGROUND AND OBJECTIVES: Peritoneal dialysis (PD) patients may be overhydrated especially when inflammation is present. We hypothesized that patients with a plasma albumin below the median value would have measurable overhydration without a proportional increase in plasma volume (PV). DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We investigated a cross-sectional sample of 46 prevalent PD patients powered to detect a proportional increase in PV associated with whole body overhydration and hypoalbuminemia. PV was determined from (125)I-labeled albumin dilution, absolute total body water from D dilution (TBW(D)), and relative hydration from multifrequency bioimpedance analysis (BIA; Xitron 4200) expressed as the extracellular water (ECW):TBW(BIA) ratio.
RESULTS: Whereas patients with plasma albumin below the median (31.4 g/dl) were overhydrated as determined both by BIA alone (ECW:TBW(BIA) 0.49 versus 0.47, P < 0.036) and the difference between estimated TBW(BIA) and measured TBW(D) (3.55 versus 0.94 L, P = 0.012), corrected PV was not different (1463 versus 1482 ml/m(2), NS). Mean PV was not different from predicted, and its variance did not correlate with any other clinical measures. Multivariate analysis showed that the only independent predictor of whole body overhydration was reduced plasma albumin.
CONCLUSIONS: Hypoalbuminemia is an important determinant of tissue overhydration in PD patients. This overhydration is not associated with an increased plasma volume. Attempts to normalize the ECW:TBW ratio in hypoalbuminemic, inflamed PD patients may lead to hypovolemia and loss of residual renal function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20538836      PMCID: PMC2924416          DOI: 10.2215/CJN.09411209

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  30 in total

1.  Accuracy and precision of flowing afterglow mass spectrometry for the determination of the deuterium abundance in the headspace of aqueous liquids and exhaled breath water.

Authors:  P Spanel; D Smith
Journal:  Rapid Commun Mass Spectrom       Date:  2001       Impact factor: 2.419

2.  A new technique for establishing dry weight in hemodialysis patients via whole body bioimpedance.

Authors:  Paul W Chamney; Matthias Krämer; Christiane Rode; Wolfgang Kleinekofort; Volker Wizemann
Journal:  Kidney Int       Date:  2002-06       Impact factor: 10.612

3.  Quantifying comorbidity in peritoneal dialysis patients and its relationship to other predictors of survival.

Authors:  Simon J Davies; Louise Phillips; Patrick F Naish; Gavin I Russell
Journal:  Nephrol Dial Transplant       Date:  2002-06       Impact factor: 5.992

4.  Comparison of body fluid distribution between chronic haemodialysis and peritoneal dialysis patients as assessed by biophysical and biochemical methods.

Authors:  J Plum; G Schoenicke; W Kleophas; W Kulas; F Steffens; A Azem; B Grabensee
Journal:  Nephrol Dial Transplant       Date:  2001-12       Impact factor: 5.992

5.  Can a reduction in extracellular fluid volume result in increased serum albumin in peritoneal dialysis patients?

Authors:  Colin H Jones; Louise Wells; John Stoves; Fiona Farquhar; Graham Woodrow
Journal:  Am J Kidney Dis       Date:  2002-04       Impact factor: 8.860

6.  Adjustment for comorbidity in studies on health status in ESRD patients: which comorbidity index to use?

Authors:  Jeannette G Van Manen; Johanna C Korevaar; Friedo W Dekker; Elisabeth W Boeschoten; Patrick M M Bossuyt; Raymond T Krediet
Journal:  J Am Soc Nephrol       Date:  2003-02       Impact factor: 10.121

7.  Fluid status, blood pressure, and cardiovascular abnormalities in patients on peritoneal dialysis.

Authors:  Constantijn J A M Konings; Jeroen P Kooman; Marc Schonck; Ruben Dammers; Emiel Cheriex; Andrea P Palmans Meulemans; Arnold P G Hoeks; Bernardus van Kreel; Ulrich Gladziwa; Frank M van der Sande; Karel M L Leunissen
Journal:  Perit Dial Int       Date:  2002 Jul-Aug       Impact factor: 1.756

8.  Assessment of fluid status in peritoneal dialysis patients.

Authors:  Constantijn J A M Konings; Jeroen P Kooman; Marc Schonck; Petronella L Cox-Reijven; Bernardus van Kreel; Ulrich Gladziwa; Joris Wirtz; Paul G Gerlag; Steven J Hoorntje; Johannes Wolters; Guido A K Heidendal; Frank M van der Sande; Karel M L Leunissen
Journal:  Perit Dial Int       Date:  2002 Nov-Dec       Impact factor: 1.756

9.  Fluid status in CAPD patients is related to peritoneal transport and residual renal function: evidence from a longitudinal study.

Authors:  Constantijn J A M Konings; Jeroen P Kooman; Marc Schonck; Dick G Struijk; Ulrich Gladziwa; Steven J Hoorntje; A Warmold van der Wall Bake; Frank M van der Sande; Karel M L Leunissen
Journal:  Nephrol Dial Transplant       Date:  2003-04       Impact factor: 5.992

10.  Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study.

Authors:  Constantijn J A M Konings; Jeroen P Kooman; Marc Schonck; Ulrich Gladziwa; Joris Wirtz; A Warmold van den Wall Bake; Paul G Gerlag; Steven J Hoorntje; Johannes Wolters; Frank M van der Sande; Karel M L Leunissen
Journal:  Kidney Int       Date:  2003-04       Impact factor: 10.612

View more
  27 in total

Review 1.  Body Fluids in End-Stage Renal Disease: Statics and Dynamics.

Authors:  Jeroen P Kooman; Frank M van der Sande
Journal:  Blood Purif       Date:  2018-12-05       Impact factor: 2.614

2.  Screening for muscle loss in patients established on peritoneal dialysis using bioimpedance.

Authors:  G H B Greenhall; A Davenport
Journal:  Eur J Clin Nutr       Date:  2016-10-26       Impact factor: 4.016

3.  Combination of low body mass index and serum albumin level is associated with chronic kidney disease progression: the chronic kidney disease-research of outcomes in treatment and epidemiology (CKD-ROUTE) study.

Authors:  Hiroaki Kikuchi; Eiichiro Kanda; Shintaro Mandai; Masanobu Akazawa; Soichiro Iimori; Katsuyuki Oi; Shotaro Naito; Yumi Noda; Takayuki Toda; Teiichi Tamura; Sei Sasaki; Eisei Sohara; Tomokazu Okado; Tatemitsu Rai; Shinichi Uchida
Journal:  Clin Exp Nephrol       Date:  2016-02-26       Impact factor: 2.801

Review 4.  The Current State of Peritoneal Dialysis.

Authors:  Rajnish Mehrotra; Olivier Devuyst; Simon J Davies; David W Johnson
Journal:  J Am Soc Nephrol       Date:  2016-06-23       Impact factor: 10.121

5.  Serum albumin changes and mortality risk of peritoneal dialysis patients.

Authors:  Xiaoxiao Wang; Qingfeng Han; Tao Wang; Wen Tang
Journal:  Int Urol Nephrol       Date:  2020-02-03       Impact factor: 2.370

Review 6.  Using Bioimpedance Spectroscopy to Assess Volume Status in Dialysis Patients.

Authors:  Frank M van der Sande; Esther R van de Wal-Visscher; Stefano Stuard; Ulrich Moissl; Jeroen P Kooman
Journal:  Blood Purif       Date:  2019-12-18       Impact factor: 2.614

7.  Serum albumin as a predictor of mortality in peritoneal dialysis: comparisons with hemodialysis.

Authors:  Rajnish Mehrotra; Uyen Duong; Sirin Jiwakanon; Csaba P Kovesdy; John Moran; Joel D Kopple; Kamyar Kalantar-Zadeh
Journal:  Am J Kidney Dis       Date:  2011-05-20       Impact factor: 8.860

8.  Sarcoidosis as a cause of unappreciated hypercalcaemia in a patient with end-stage renal disease on peritoneal dialysis.

Authors:  Ami Kwon; Eun Sil Koh; Sungjin Chung; Yong Kyun Kim
Journal:  BMJ Case Rep       Date:  2013-08-01

Review 9.  Peritoneal dialysis--current status and future challenges.

Authors:  Simon J Davies
Journal:  Nat Rev Nephrol       Date:  2013-05-21       Impact factor: 28.314

10.  Excess fluid distribution affects tacrolimus absorption in peritoneal dialysis patients.

Authors:  Tadashi Sofue; Masashi Inui; Hideyasu Kiyomoto; Kumiko Moriwaki; Taiga Hara; Kazunori Yamaguchi; Noriyasu Fukuoka; Kazuko Banno; Akira Nishiyama; Yoshiyuki Kakehi; Masakazu Kohno
Journal:  Clin Exp Nephrol       Date:  2012-12-27       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.